172 related articles for article (PubMed ID: 35143806)
21. The anti-carcinogenesis properties of erianin in the modulation of oxidative stress-mediated apoptosis and immune response in liver cancer.
Zhang X; Wang Y; Li X; Yang A; Li Z; Wang D
Aging (Albany NY); 2019 Nov; 11(22):10284-10300. PubMed ID: 31754081
[TBL] [Abstract][Full Text] [Related]
22. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
23. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
[TBL] [Abstract][Full Text] [Related]
24. Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation.
Nakade J; Takeuchi S; Nakagawa T; Ishikawa D; Sano T; Nanjo S; Yamada T; Ebi H; Zhao L; Yasumoto K; Matsumoto K; Yonekura K; Yano S
J Thorac Oncol; 2014 Jun; 9(6):775-83. PubMed ID: 24828661
[TBL] [Abstract][Full Text] [Related]
25. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
Lu S; Gao Y; Huang X; Wang X
Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
[TBL] [Abstract][Full Text] [Related]
26. Identification of Pyruvate Carboxylase as the Cellular Target of Natural Bibenzyls with Potent Anticancer Activity against Hepatocellular Carcinoma via Metabolic Reprogramming.
Sheng Y; Chen Y; Zeng Z; Wu W; Wang J; Ma Y; Lin Y; Zhang J; Huang Y; Li W; Zhu Q; Wei X; Li S; Wisanwattana W; Li F; Liu W; Suksamrarn A; Zhang G; Jiao W; Wang F
J Med Chem; 2022 Jan; 65(1):460-484. PubMed ID: 34931827
[TBL] [Abstract][Full Text] [Related]
27. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
[TBL] [Abstract][Full Text] [Related]
28. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
[TBL] [Abstract][Full Text] [Related]
29. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling.
Liu P; Atkinson SJ; Akbareian SE; Zhou Z; Munsterberg A; Robinson SD; Bao Y
Sci Rep; 2017 Oct; 7(1):12651. PubMed ID: 28978924
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells.
Carbajo-Pescador S; Ordoñez R; Benet M; Jover R; García-Palomo A; Mauriz JL; González-Gallego J
Br J Cancer; 2013 Jul; 109(1):83-91. PubMed ID: 23756865
[TBL] [Abstract][Full Text] [Related]
31. Identification and Characterization of a Novel Protein ASP-3 Purified from
Guo Z; Shi H; Li C; Luo Y; Bi S; Yu R; Wang H; Liu W; Zhu J; Huang W; Song L
Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31505835
[TBL] [Abstract][Full Text] [Related]
32. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.
Chen CK; Yu WH; Cheng TY; Chen MW; Su CY; Yang YC; Kuo TC; Lin MT; Huang YC; Hsiao M; Hua KT; Hung MC; Kuo ML
Sci Rep; 2016 Aug; 6():31398. PubMed ID: 27507763
[TBL] [Abstract][Full Text] [Related]
34. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
Liu Y; Poon RT; Li Q; Kok TW; Lau C; Fan ST
Cancer Res; 2005 May; 65(9):3691-9. PubMed ID: 15867364
[TBL] [Abstract][Full Text] [Related]
35. Plumbagin restrains hepatocellular carcinoma angiogenesis by suppressing the migration and invasion of tumor-derived vascular endothelial cells.
Wei Y; Yang Q; Zhang Y; Zhao T; Liu X; Zhong J; Ma J; Chen Y; Zhao C; Li J
Oncotarget; 2017 Feb; 8(9):15230-15241. PubMed ID: 28122355
[TBL] [Abstract][Full Text] [Related]
36. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
[TBL] [Abstract][Full Text] [Related]
37. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
Cho HD; Lee KW; Won YS; Kim JH; Seo KI
J Ethnopharmacol; 2020 Jun; 256():112664. PubMed ID: 32045685
[TBL] [Abstract][Full Text] [Related]
38. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium/calmodulin-dependent ferroptosis.
Chen P; Wu Q; Feng J; Yan L; Sun Y; Liu S; Xiang Y; Zhang M; Pan T; Chen X; Duan T; Zhai L; Zhai B; Wang W; Zhang R; Chen B; Han X; Li Y; Chen L; Liu Y; Huang X; Jin T; Zhang W; Luo H; Chen X; Li Y; Li Q; Li G; Zhang Q; Zhuo L; Yang Z; Tang H; Xie T; Ouyang X; Sui X
Signal Transduct Target Ther; 2020 May; 5(1):51. PubMed ID: 32382060
[TBL] [Abstract][Full Text] [Related]
39. Apatinib suppresses the migration, invasion and angiogenesis of hepatocellular carcinoma cells by blocking VEGF and PI3K/AKT signaling pathways.
Song J; Guan Z; Song C; Li M; Gao Z; Zhao Y
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846786
[TBL] [Abstract][Full Text] [Related]
40. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways.
Yang J; Pei H; Luo H; Fu A; Yang H; Hu J; Zhao C; Chai L; Chen X; Shao X; Wang C; Wu W; Wan L; Ye H; Qiu Q; Peng A; Wei Y; Yang L; Chen L
Oncotarget; 2017 Jan; 8(1):915-932. PubMed ID: 27906672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
